Zobrazeno 1 - 10
of 71
pro vyhledávání: '"R. T. Alekperov"'
Autor:
R. U. Shayakhmetova, L. P. Ananyeva, M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, L. A. Garzanova, M. V. Cherkasova, R. T. Alekperov
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 1, Pp 48-54 (2020)
Various clinical and immunological phenotypes of systemic sclerosis (SS) differ in the frequency and severity of manifestations of the disease, the progression of damage to internal organs, and prognosis. The detection rate of anti-U1-ribonucleoprote
Externí odkaz:
https://doaj.org/article/56c9458eb80046748424290ef5553d6f
Autor:
R. T. Alekperov
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 435-444 (2019)
Systemic lupus erythematosus, systemic sclerosis, inflammatory myopathy and rheumatoid arthritis are systemic connective tissue disorders which are characterized by heterogeneous clinical symptoms and variable course. To date, updated diagnostic crit
Externí odkaz:
https://doaj.org/article/4f880f1ad83d4205a4746a028a2a30dd
Autor:
O. V. Dobrovolskaya, N. V. Demin, A. V. Smirnov, L. A. Garzanova, N. V. Toroptsova, R. T. Alekperov
Publikováno v:
Современная ревматология, Vol 13, Iss 1, Pp 58-63 (2019)
Objective: to assess the frequency of a reduction in bone mineral density (BMD) and its association with traditional risk factors and clinical parameters in patients with systemic scleroderma (SSD).Patients and methods. The investigation included 330
Externí odkaz:
https://doaj.org/article/5290b5dcb8364328990b8dc582945063
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 5, Pp 569-573 (2018)
Objective: to investigate the levels and clinical associations of vascular endothelial growth factor (VEGF) and its type 2 receptor (VEGFR-2) in patients with systemic sclerosis (SSc).Subjects and methods. The investigation enrolled 46 patients aged
Externí odkaz:
https://doaj.org/article/565eb3e5b1d445c2ba84d7721a0bbcff
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 8, Pp 628-634 (2018)
Aim: To assess serum levels of vascular endothelial growth factor (VEGF) and its clinical correlates in patients with systemic sclerosis (SSc). Materials and methods: Forty six (46) patients with SSc aged from 19 to 77 years (median, 50 years), with
Externí odkaz:
https://doaj.org/article/fd314e0e0e5e4b188f6575383b45a468
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 1, Pp 32-36 (2017)
Objective: to estimate heart rate variability (HRV) in patients with systemic sclerosis (SS) and to investigate their relationship to echocardiographic structural and functional changes in the heart.Subjects and methods. The investigation enrolled 12
Externí odkaz:
https://doaj.org/article/2177294d7bd743b488b5d2c8f03d8eae
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 6, Pp 687-692 (2017)
Objective: to determine the frequency of traditional risk factors (TRFs) for cardiovascular diseases (CVD) in patients with systemic sclerosis (SS) and to analyze their relationship to the clinical manifestations of SS, as well as to structural chang
Externí odkaz:
https://doaj.org/article/af8e26b1577c4b0882b1b268bba5e562
Autor:
M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, R. T. Alekperov, M. V. Cherkasova, E. N. Aleksandrova, L. P. Ananyeva
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 4, Pp 418-423 (2016)
Objective: to estimate frequency of autoantibodies in a cohort of Russian patients with systemic sclerosis (SS) and to investigate clinical associations of these autoantibodies.Subjects and methods. In 2012 to 2015, the investigation enrolled 300 pat
Externí odkaz:
https://doaj.org/article/9a947e073851441d9b0cef4c38421482
Autor:
R. T. Alekperov, N. V. Toroptsova
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 43, Pp 90-99 (2016)
Systemic sclerosis is an autoimmune inflammatory disease of connective tissue with multi-syndrome clinical manifestations. Skeletal damage is considered to be one of significant contributors to the quality of life of these patients. The purpose of th
Externí odkaz:
https://doaj.org/article/56dd34c4dc4547e6ac8569f472be3c68
Autor:
R. T. Alekperov
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 35, Pp 94-100 (2016)
Raynaud’s phenomenon (RP) is a common medical condition with prevalence in the population about 3–5%. RP is subdivided into primary form manifesting mainly in children and adolescents, and secondary RP affecting elder patients. Secondary RP is fr
Externí odkaz:
https://doaj.org/article/c849140fdef747e09fb5b0cbd03db08b